{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:30:22Z","timestamp":1794353422859,"version":"4.9.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020992","name":"Caisse nationale de l'Assurance Maladie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lanepe.2026.101756","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:40:48Z","timestamp":1781934048000},"page":"101756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability Study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-7759","authenticated-orcid":false,"given":"Marie-Joelle","family":"Jabagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1273-8988","authenticated-orcid":false,"given":"Am\u00e9lie","family":"Gabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Tr\u00e9luyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epiphane","family":"Kolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9226-9071","authenticated-orcid":false,"given":"Antoine","family":"Rachas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Oli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10340","key":"10.1016\/j.lanepe.2026.101756_bib1","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101756_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-2600(24)00184-X","article-title":"Respiratory syncytial virus vaccines: the future is bright","volume":"12","author":"Medicine","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"17","key":"10.1016\/j.lanepe.2026.101756_bib3","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMoa2106062","article-title":"Prefusion F protein\u2013based respiratory syncytial virus immunization in pregnancy","volume":"386","author":"Sim\u00f5es","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.lanepe.2026.101756_bib4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101756_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2352-4642(25)00155-5","article-title":"Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study","volume":"9","author":"Williams","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.lanepe.2026.101756_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1473-3099(25)00624-3","article-title":"Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case\u2013control study and cohort analysis","volume":"26","author":"McLachlan","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101756_bib7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1473-3099(25)00156-2","volume":"25","author":"Marc","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanepe.2026.101756_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamapediatrics.2025.5778","article-title":"Effectiveness and impact of maternal RSV immunization and nirsevimab on medically attended RSV in US children","volume":"180","author":"Moline","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101756_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400275","article-title":"Nirsevimab effectiveness at preventing RSV-related hospitalization in infants","volume":"4","author":"Jabagi","year":"2025","journal-title":"NEJM Evid"},{"key":"10.1016\/j.lanepe.2026.101756_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jama.2025.24082","article-title":"Nirsevimab vs RSVpreF vaccine for respiratory syncytial virus\u2013related hospitalization in newborns","volume":"335","author":"Jabagi","year":"2026","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.lanepe.2026.101756_bib11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMc2302134","article-title":"Stroke, myocardial infarction, and pulmonary embolism after bivalent booster","volume":"388","author":"Jabagi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2026.101756_bib12","article-title":"Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people","volume":"8","author":"Semenzato","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101756_bib13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.lanepe.2026.101756_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.10.053","article-title":"Enhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth","volume":"232","author":"Jasset","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101756_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"key":"10.1016\/j.lanepe.2026.101756_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-084909","article-title":"Starting right: aligning eligibility and treatment assignment at time zero when emulating a target trial","volume":"392","author":"Fu","year":"2026","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101756_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.4666","article-title":"Risk factors for severe disease among children hospitalized with respiratory syncytial virus","volume":"8","author":"Kirolos","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanepe.2026.101756_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2458-9-33","article-title":"Ecological association between a deprivation index and mortality in France over the period 1997 - 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death","volume":"9","author":"Rey","year":"2009","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101756_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101756_bib19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1037\/a0019623","article-title":"Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research","volume":"15","author":"Harder","year":"2010","journal-title":"Psychol Methods"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101756_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2202\/1557-4679.1146","article-title":"Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses","volume":"5","author":"Austin","year":"2009","journal-title":"Int J Biostat"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101756_bib22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/sim.8502","article-title":"Variance estimation when using propensity-score matching with replacement with survival or time-to-event outcomes","volume":"39","author":"Austin","year":"2020","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101756_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/cir007","article-title":"\u201cHerd immunity\u201d: a rough guide","volume":"52","author":"Fine","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101756_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0891-5520(05)70278-6","article-title":"Vaccines in pregnancy","volume":"15","author":"Munoz","year":"2001","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101756_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0031-3955(05)70217-0","article-title":"A step ahead. Infant protection through maternal immunization","volume":"47","author":"Munoz","year":"2000","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101756_bib28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101756_bib29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jpids\/piae101","article-title":"Parental socioeconomic status and an infant's risk of hospital admission for respiratory syncytial virus","volume":"13","author":"Koivisto","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101756_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.4341","article-title":"Sociodemographic characteristics of infants receiving nirsevimab","volume":"8","author":"Boutin","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101756_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.33530","article-title":"Social and regional inequalities in maternal respiratory syncytial virus vaccination in France","volume":"8","author":"Gabet","year":"2025","journal-title":"JAMA Netw Open"}],"updated-by":[{"DOI":"10.1016\/j.lanepe.2026.101930","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000}}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T08:28:32Z","timestamp":1785745712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776226001687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S2666776226001687"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101756","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability Study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101756"}}